nodes	percent_of_prediction	percent_of_DWPC	metapath
Loteprednol—Dexamethasone—NOS2—bile duct cancer	0.42	0.42	CrCbGaD
Loteprednol—Triamcinolone—PTGS2—bile duct cancer	0.253	0.253	CrCbGaD
Loteprednol—Betamethasone—PTGS2—bile duct cancer	0.207	0.207	CrCbGaD
Loteprednol—Dexamethasone—PTGS2—bile duct cancer	0.12	0.12	CrCbGaD
